ReShape Lifesciences Inc. today announces that the United States Patent and Trademark Office (“USPTO”) has issued an Issue Notification for U.S. Patent Number 10010441 entitled “Gastric Restriction Device for Treating Obesity,” which covers a patent application regarding the Company’s Gastric Vest System (the “ReShape Vest”).

Researchers have found that when one member of a couple commits to losing weight, the chances are good their partner…

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced an…

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company and its products will be discussed during the Metabolic and Bariatric Sessions of the Minimally Invasive Surgery Symposium (MISS) taking place in Las Vegas from March 6-9, 2018.

It’s that time of year again — when millions of Americans begin working on New Year’s resolutions that most likely…

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the…

A new study has also found that people with a higher body mass index (BMI) are more likely to develop dementia than those with a normal body weight.

According to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology, diabetes and high BMI over 25 kg/m2 were the cause of 5.6 percent of new cancer cases worldwide.

Obesity Rate in UAE is Estimated to be Twice the Worldwide Rate San Clemente, Calif., December 13, 2017 – ReShape…

After decades of sharp increases in obesity, a newly published survey called ACTION (Awareness, Care & Treatment In Obesity Management)…